Oral methadone for cancer pain: No indication of Q-T interval prolongation or torsades de pointes [1]

Journal of Pain and Symptom Management

Volumn 28, Issue 4, 2004, Pages 301-303

  Reddy, Suresh ^a   Fisch, Michael ^a   Bruera, Eduardo ^a  

^a USA ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; DROPERIDOL; ERYTHROMYCIN; HALOPERIDOL; METHADONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OPIATE; QUININE; TRICYCLIC ANTIDEPRESSANT AGENT;

CANCER PAIN; CANCER PATIENT; DRUG BIOAVAILABILITY; DRUG DOSE; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAM; HEART VENTRICLE ARRHYTHMIA; HUMAN; LETTER; MAINTENANCE THERAPY; OUTPATIENT; PRESCRIPTION; QT PROLONGATION; SUDDEN DEATH; TORSADE DES POINTES;

ANALGESICS, OPIOID; ARRHYTHMIA; ELECTROCARDIOGRAPHY; HEART RATE; HUMANS; METHADONE; NEOPLASMS; PAIN; PALLIATIVE CARE; TORSADES DE POINTES; TREATMENT OUTCOME; UNITED STATES;

EID: 4744352736     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2004.07.001     Document Type: Letter

References (12)

1. M.P. Davis, and D. Walsh Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration Support Care Cancer 9 2001 63 83
2. C. Ripamonti, L. Groff, and C. Brunelli Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? J Clin Oncol 16 10 1998 3216 3221
3. A.L. Gorman, K.J. Elliott, and C.E. Inturrisi The d-and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord Neurosci Lett 223 1997 5 8
4. M.J. Krantz, L. Lewkowiez, and H. Hays Torsade de pointes associated with very-high-dose methadone Ann Intern Med 137 6 2002 501 504
5. M.J. Krantz, I.B. Kutinsky, A.D. Robertson, and P.S. Mehler Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes Pharmacotherapy 23 6 2003 802 805
6. C.A. Kornick, M.J. Kilborn, and J. Santiago-Palma QTc interval prolongation associated with intravenous methadone Pain 105 3 2003 499 506
7. M. Gil, M. Sala, and I. Anguera QT prolongation and torsades de pointes in patients infected with human immunodeficiency virus and treated with methadone Am J Cardiol 92 8 2003 995 997
8. P.W. Walker, D. Klein, and L. Kasza High dose methadone and ventricular arrhythmias: a report of three cases Pain 103 3 2003 321 324
9. B.A. Martell, J.H. Arnsten, R. Beevash, and M.N. Gourevitch The impact of methadone. Induction on cardiac conduction in opiate users Ann Intern Med 139 2003 154 155
10. Reddy S, Bruera E, Willey J, Burkett A, Fisch M. Oral methadone for cancer pain: no indication of QT interval prolongation or torsades de pointes. In: Proceedings of the 39th Annual Meeting of the American Society of Clinical Oncology; May 31-June 3, 2003; Chicago, IL. Abstract 3133.
11. Y.G. Yap, and J. Camm Risk of torsades de pointes with non-cardiac drugs. Doctors need to be aware that many drugs can cause QT prolongation BMJ 320 7243 2000 1158 1159
12. M.A. Roden Drug-induced prolongation of the QT-interval N Engl J Med 350 2004 1015 1022